Press release
Hospital Infection Therapeutics Market Size, Share, Overview, Key Players and Opportunities 2022-2027
Hospital infection therapeutics refers to drugs or medications used to treat diseases or infections. They can be acquired from viral, bacterial and fungal pathogens present in hospitals, nursing homes, rehabilitation centers, outpatient clinics, and other treatment centers. Therapeutics, such as antibacterial, antiviral, antifungal, and infection-based drugs, are used to prevent hospital-acquired infections (HAIs) like urinary tract infections (UTI), pneumonia, surgical site infection, and bloodstream infections (BSI).
Request for a PDF sample of this report: https://www.imarcgroup.com/hospital-infection-therapeutics-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Hospital Infection Therapeutics Market Trends:
The global hospital infection therapeutics market is primarily driven by the rising prevalence of chronic diseases that have increased hospital admissions and cases of HAIs. The growing geriatric population and rising healthcare expenditure are also escalating the demand for these therapeutics. Furthermore, there has been a development of advanced therapies, drugs, vaccines and coverings that can be used for the treatment of infections with specific symptoms. Moreover, extensive investment in research and development (R&D) activities to develop new HAI drugs, such as Zerbaxa by Merck & Co., for the treatment of ventilator-associated bacterial pneumonia (VABP), are expected to influence the market growth in the near future.
Hospital Infection Therapeutics Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global hospital infection therapeutics market has also been examined along with the profiles of the key players.
Some of these key players include:
Allergan Plc (AbbVie Inc.)
AstraZeneca Plc
Bayer Aktiengesellschaft
Bristol-Myers Squibb Company
Hoffmann-La Roche AG (Roche Holding AG)
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co. Inc
Pfizer Inc.
Sanofi S.A.
Key Market Segmentation:
The report has segmented the hospital infection therapeutics market based on drug type, indication, and region.
Breakup by Drug Type:
Anti-bacterial Drugs
Anti-fungal Drugs
Anti-viral Drugs
Others
Breakup by Indication:
Blood Stream Infections
Urinary Tract Infections
Surgical Site Infections
Pneumonia
Others
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2393&flag=C
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Apheresis Equipment Market: https://bit.ly/3M93n4m
RNA Interference Drug Delivery Market: https://bit.ly/3ROPjyp
Multiple Sclerosis Therapies Market: https://bit.ly/3rzqFXH
Portable Medical Ventilators Market: https://bit.ly/3EgRNCq
Nucleic Acid Labelling Market: https://bit.ly/3V4i4Kb
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hospital Infection Therapeutics Market Size, Share, Overview, Key Players and Opportunities 2022-2027 here
News-ID: 2758616 • Views: …
More Releases from IMARC Group
Supercapacitor Market Size to Reach $31.07B by 2033: Trends & Opportunities
Market Overview:
The supercapacitor market is experiencing rapid growth, driven by electrification of automotive systems, renewable energy and grid stabilization, and expansion of industrial automation and robotics. According to IMARC Group's latest research publication, "Supercapacitor Market Size, Share, Trends and Forecast by Product Type, Module Type, Material Type, End Use Industry, and Region, 2025-2033", the global supercapacitor market size was valued at USD 6.41 Billion in 2024. Looking forward, IMARC Group…
Bicycle Market Size to Surpass $102.05B by 2033: Growth & Insights
Market Overview:
The bicycle market is experiencing rapid growth, driven by global expansion of cycling infrastructure, rising health consciousness and preventative wellness, and technological advancements in e-bike propulsion. According to IMARC Group's latest research publication, "Bicycle Market Size, Share, Trends and Forecast by Type, Technology, Price, Distribution Channel, End User, and Region, 2025-2033", The global bicycle market size was valued at USD 67.42 Billion in 2024. Looking forward, IMARC Group estimates…
Baby Food and Infant Formula Market to Reach USD 84.06 Billion by 2033, Growing …
Market Overview:
The Baby Food and Infant Formula Market is experiencing steady expansion, driven by Increasing Awareness of Nutritional Needs for Infants, Rising Number of Working Women, and Technological Advancements and Product Innovation. According to IMARC Group's latest research publication, "Baby Food and Infant Formula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global baby food and infant formula market size reached USD 53.73 Billion in 2024.…
Breakfast Cereals Market to Reach USD 149.07 Billion by 2033, Growing at a CAGR …
Market Overview:
The Breakfast Cereals Market is experiencing rapid growth, driven by Health and Wellness Awareness, Busy Lifestyles and On-the-Go Demand and Rising Disposable Incomes and Global Market Expansion . According to IMARC Group's latest research publication, "Breakfast Cereals Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global breakfast cereals market size was valued at USD 108.89 Billion in 2024. Looking forward, IMARC Group estimates…
More Releases for Infection
Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Infection Prevention Market?
In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market…
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market?
The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization.
The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven…
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The yeast infection…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing…
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026.
The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,…
